Enquire now in case of any assistance needed

Pediatric Leukemia Treatment Cost in India: A Cost Guide

  • Starting From: USD 4000-20000

  • Icon

    Procedure Type: Medical Management

  • Icon

    Hospitalization Days: 4-5 Days

  • Icon

    Procedure Duration: 0.5-1 Hrs

  • Icon

    Recovery Time: 104-156 Weeks

  • Icon

    Success Rate: 80%

What is the Cost of Pediatric Leukemia Treatment in India? 

Pediatric Leukemia treatment cost in India starts from USD 4,000, with expenses rising to USD 20,000 for advanced therapies like stem cell transplants. Costs depend on the type of leukemia, treatment duration, and the availability of hospital facilities. The most common form, Acute Lymphoblastic Leukemia (ALL), affects up to 80% of cases. Treatment involves long-term medical management, with recovery spanning 2–3 years and success rates ranging between 60% to 80%.

Get Your Pediatric Leukemia Treatment Cost in India: A Cost Guide

What is Pediatric Leukemia?

Pediatric Leukemia is a cancer that begins in the bone marrow—the soft tissue inside bones where blood cells are made. In this disease, the marrow creates abnormal white blood cells that overcrowd the healthy ones, weakening the body's ability to fight infections, transport oxygen, and prevent bleeding. Acute Lymphoblastic Leukemia (ALL), the most frequent form, representing nearly 75–80% of leukemia cases in children.

If you're checking the Pediatric Leukemia treatment cost in India, the stem cell transplant procedure is among the higher-priced ones due to pre- and post-transplant care, hospitalization, and the cost of stem cells.

Who Should Get Pediatric Leukemia Treatment?

  • Acute Myeloid Leukemia (AML) – High Risk or Relapsed: Children with poor genetic markers or no remission after standard chemotherapy for AML are at high risk. Doctors may then consider stem cell transplants after a second remission, replacing damaged bone marrow with healthy cells to reduce relapse chances. For relapsed AML, transplantation is urgent, especially if chemotherapy fails. Donor match, health, and timing are key factors in this intensive procedure.
  • Acute Lymphoblastic Leukemia (ALL) – Second or Later Remission: When ALL Returns after initial treatment, especially within two years, it becomes more aggressive and more challenging to control. Children often receive a stem cell transplant during the second remission, offering better control over recurring leukemia and supporting long-term survival. Treatment may be recommended if the child has a specific chromosomal abnormality, like the Philadelphia chromosome. Close monitoring is crucial both before and after the transplant to detect complications promptly and enhance outcomes.
  • Juvenile Myelomonocytic Leukemia (JMML): This rare type of leukemia mainly affects toddlers and young children. It doesn’t respond well to chemotherapy, and the only curative option is a stem cell transplant. The disease causes the rapid growth of abnormal white blood cells, which crowd out healthy ones. Without a transplant, JMML can progress quickly and become fatal. A matched donor—either a sibling or a registry match—is used to rebuild the child’s blood-forming system. Early diagnosis and fast action can improve the odds of recovery.
  • Chronic Myeloid Leukemia (CML) – In Blast Crisis or Resistant to Drugs: Although CML is more common in adults, a small number of children are diagnosed with it. If standard targeted therapy (like tyrosine kinase inhibitors) stops working, or if the disease reaches an advanced phase called blast crisis, this transplant becomes the next viable step. The transplant can replace the entire blood-forming system, helping the child restart with healthy marrow. It’s a demanding process that requires careful selection and post-transplant support to maintain stability.

Additional Considerations

  • Donor Match Availability: Finding a compatible donor is crucial. Siblings are usually tested first, but many families rely on unrelated donors from global registries. The search itself adds to hospital timelines and expenses. 
  • Pre-Transplant Conditioning: Children undergo intense chemotherapy or radiation to destroy diseased cells before receiving donor marrow. This phase is physically demanding and requires complete isolation in sterile units. Complications during this period, like infections or organ issues, can escalate care needs and directly influence the Childhood Leukemia cost in India.
  • Long-Term Monitoring and Relapse Risk: Transplant doesn’t end with hospital discharge. Regular bone marrow checks, immune system monitoring, and potential rehospitalizations are part of post-transplant care. Some children also need lifelong medication. 

Always consult a specialized surgeon to determine if you are a candidate for a stem cell transplant.

Pediatric Leukemia Treatment Cost in India at a Glance

The Leukemia treatment cost in India for children varies based on hospital facilities, city, type of leukemia, treatment plan, and oncologist’s expertise:

  • Minimum Cost: INR 3,33,200 (Approx. USD 4,000)
  • Average Cost: INR 5,00,000 – INR 10,00,000 (Approx. USD 6,000 – USD 12,000)
  • Maximum Cost: INR 20,00,000 (Approx. USD 24,000)

These estimates typically apply to standard treatment, which includes chemotherapy, hospital stay, diagnostics, and follow-up care. Stem cell transplants or complications may increase costs.

Factors Affecting Pediatric Leukemia Treatment Cost in India

A lot of elements impact the Leukemia treatment cost in India. Here are some of the factors affecting Pediatric Leukemia treatment costs in India:

1. Hospital Type & Location

  • Top pediatric oncology centers in metro cities like Mumbai, Delhi, or Chennai usually charge more. These hospitals provide access to advanced pediatric cancer units and skilled oncologists. 

2. Type of Leukemia & Treatment Plan

  • Acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) follow different treatment regimens. Chemotherapy alone may be cost-effective, while bone marrow transplant or immunotherapy increases the Leukemia treatment cost in India.
  • Advanced stages typically require more extended hospital stays and more potent medications, which can increase the total bill.

3. Doctor’s Expertise & Team Support

  • Senior pediatric hemato-oncologists with a strong clinical track record may charge more for consultations and treatment supervision. Highly coordinated care among oncologists, pediatricians, and transplant teams can impact the cost of Leukemia treatment in India for children.

4. Type of Room Chosen

  • Selecting a deluxe or private room raises accommodation expenses. Pediatric leukemia treatment involves prolonged hospital stays, ranging from weeks to months.

Know Your Treatment Cost

Get a cost estimate based on your condition and hospital preferences.

City-Wise Cost of Pediatric Leukemia Surgery in India

Here’s the leukemia treatment cost breakdown across major Indian cities. USD conversions are approximate and based on prevailing rates.

Table 1: Leukemia Treatment Cost Across Major Indian Cities in INR and USD

City

Min Cost (INR)

Max Cost (INR)

Min Cost (USD)

Max Cost (USD)

New Delhi

1,00,000

18,00,000

3,498

21,060

Mumbai

3,00,000

20,00,000

10,496

23,410

Bengaluru

2,00,000

18,00,000

6,997

21,060

Chennai

1,50,000

19,00,000

5,248

22,235

Hyderabad

2,50,000

20,00,000

8,747

23,410

Kolkata

2,00,000

19,00,000

6,997

22,235

Pune

2,80,000

20,00,000

9,797

23,410

Chandigarh

50,000

18,00,000

1,749

21,060

Gurugram

5,00,000

20,00,000

17,494

23,410

Cities such as Delhi, Mumbai, and Bengaluru often reflect higher treatment ranges due to the presence of top-tier pediatric oncology centers, seasoned hematologists, and cutting-edge technologies. For families seeking affordable Pediatric Leukemia treatment in India, hospitals in cities like tier-2 hubs like Chandigarh and Kolkata usually offer more affordable treatment plans without compromising medical quality.

India vs. Other Countries: Pediatric Leukemia Treatment Package in India vs Global Costs

Medical travelers often weigh their options across different countries, seeking to make informed decisions that balance cost savings with quality care. Below is a comparative look at pediatric leukemia treatment pricing globally:

Table 2: Leukemia Treatment Cost Across India and other cities in INR and USD

Country

Approx. Range (USD)

India

4,000 – 35,000

Turkey

18,000 – 45,000

Thailand

4,500 – 80,000

UAE

20,000 – 55,000

UK

8,712 – 16,551

USA

12,000 – 1,17,000

Pediatric AML treatment in India is one of the most affordable options globally. India offers budget-conscious pricing, NABH-accredited children’s hospitals, and hematologists with international experience. 

Parents often choose India because it delivers advanced protocols like chemotherapy, bone marrow transplant, and supportive pediatric oncology care without draining life savings.

Additional Expenses: Pre- and Post-Pediatric Leukemia Costs

Pre-Treatment Costs

  • Specialist Pediatric Hematologist Consultations: INR 400 – 2,000 (USD 4.68 – USD 23.41)
  • Bone Marrow Biopsy & Aspiration: INR 500 – 2,700 (USD 5.85 – USD 31.61)
  • Flow Cytometry: INR 2,500 – 8,000 (USD 29.26 – USD 93.64)
  • Cytogenetic Testing: INR 2,000 – 60,000 (USD 23.41 – USD 701.95)
  • MRI or PET Scan (if needed): INR 4,500 – 40,000 (USD 52.67 – USD 467.97)
  • Routine Blood Panels & Organ Function Tests: INR 2,000 – 14,000 (USD 23.41 – USD 163.55)
  • Infection Screening & Immunology Panels: INR 11,660 – 13,500 (USD 136.37 – USD 157.93)

Patients with hypertension, diabetes, or kidney dysfunction may need extra testing.

Post-Treatment Costs

  • Medications (including antibiotics, antiemetics, and maintenance chemo): INR 5,000 – 20,000/month (USD 60 – USD 240/month)
  • Follow-Up Visits: INR 1,000 – 3,000 per visit (USD 12 – USD 36)
  • Blood Transfusions (if required): INR 2,000 – 5,000 per unit (USD 24 – USD 60)
  • Supportive Therapies (e.g., nutritional, psychological): INR 2,000 – 6,000/month (USD 24 – USD 72/month)

Hospital Readmissions due to infections or side effects can increase overall expenses considerably.

Know Your Treatment Cost

Get a cost estimate based on your condition and hospital preferences.

Insurance and Financing Options

Most leading health insurance plans in India typically include coverage for pediatric leukemia treatment under their hospitalization and oncology benefits. This applies to both Pediatric ALL treatment costs in India and Pediatric AML treatment costs in India, as these are medically required interventions.

Families are urged to read the policy wording carefully—look for clauses on chemotherapy, ICU limits, room category caps, and pre-approval steps. For families without insurance, several top hospitals partner with NBFCs and fintech lenders to offer EMI-based options at 0% interest.

Tips to Reduce Pediatric Leukemia Treatment Costs

Here are some tips to reduce Pediatric leukemia treatment cost in India:

  • Choose Tier 2 Cities: Consider reputable cancer centers in cities like Nagpur, Jaipur, or Bhubaneswar, where Pediatric AML Treatment Cost India are typically 25–35% lower than in metro hospitals.
  • Prefer Treatment Packages: Look for pediatric oncology departments that offer comprehensive treatment plans covering chemotherapy sessions, diagnostic tests, hospital stays, consultation fees, and supportive care. 
  • Use Insurance Wisely: Get pre-authorization well in advance. Cashless services ease the financial stress, especially during multi-cycle chemotherapy and critical care admissions.
  • Complete Early Tests Outside: Save on pre-admission expenses by getting initial tests like CBC, bone marrow biopsy, or imaging done at NABL-accredited diagnostic centers.

Why Choose MediJourney for Leukemia Treatment Surgery Package in India?

Choosing MediJourney for your child’s leukemia care in India means you’re not alone in the fight. We partner with top-tier pediatric oncologists and trusted hospitals across the country to give your child access to high-quality treatment at the correct cost. The Leukemia treatment cost in India through MediJourney is thoughtfully planned and completely transparent.

From securing doctor appointments at India’s leading cancer centers to helping families handle travel, stay, and follow-ups, our support is hands-on and thorough. We understand that navigating the cost of Leukemia treatment in India for children can be overwhelming. We keep you updated every step of the way, with no sudden bills.

Let us be your partner in this overwhelming time. Contact us to know more.

FAQs About Leukemia Treatment Cost in India

Q1. What is the average cost of Pediatric Leukemia (Childhood Leukemia) treatment in India?

Answer: The cost of Pediatric Leukemia Treatment in India usually ranges between INR 5 lakh and INR 25 lakh (approx. USD 6,000 to USD 30,000), depending on the diagnosis—ALL (Acute Lymphoblastic Leukemia) or AML (Acute Myeloid Leukemia). Treatment at government hospitals may be more affordable.

Q2. What does the cost of Pediatric Leukemia treatment typically include?

Answer: Childhood Leukemia cost in India is not a single-line bill. It often includes:

  • Hospital admission and ICU care
  • Doctor and pediatric oncologist consultations
  • Chemotherapy cycles
  • Blood transfusions
  • Bone marrow biopsy and lumbar puncture

Q3. Why does the cost of Pediatric Leukemia treatment vary so much?

Answer: The Pediatric Leukemia treatment cost in India changes based on:

  • Type of leukemia (ALL is typically less expensive than AML)
  • Stage at diagnosis
  • Hospital location (metro vs. Tier 2 cities)
  • Hospital type (government, trust-run, or private)

Q4. How much does chemotherapy for Pediatric Leukemia cost in India?

Answer: Chemotherapy alone can range from INR 3 lakh to INR 10 lakh (approx. USD 3,500 to USD 12,000) based on the number of sessions, drugs used, duration of treatment, and hospital protocols. For Childhood Leukemia costs in India, chemotherapy is usually the most significant part of the overall expense. Some regimens span over 2 to 3 years with different intensities.

Leading Hospitals for Pediatric Leukemia Treatment in India

Choose Your Preferred City

Doctors for Pediatric Leukemia Treatment in India

Reviewer

Dr. Pawan Kumar is a leading Bone Marrow Transplant Surgeon. He has an experience of more than 16 years. His core competencies include malignant and non-malignant hematologic disorders, particularly Thalassemia and Aplastic Anaemia....

Blogs

The Art of Effective Communication